CD8A and neoplasm: Prior studies have shown that upregulation of MHC-I leads to targeting by cytotoxic CD8+ T cells for cell death (25, 37, 50), and downregulation of MHC-I has been associated with tumor cell and viral mechanisms to evade the innate immune response (25, 36).